Few experimental studies have evaluated the response of the hypertrophied heart to ischemia, and little is known about the role of ATP decline and lactate accumulation in ischemic hypertrophied hearts. The first descriptions of ischemic contracture or "stone heart" were noted in patients with left ventricular hypertrophy,8 suggesting that the hypertrophied myocardium may have an enhanced suscep-
T he final outcome of persistent cardiac ischemia is myocardial necrosis. The mechanisms responsible for this transition from normal to irreversibly injured myocardium are of interest to both clinicians and basic scientists. The development of irreversible myocardial injury has been associated with decreased tissue ATP levels.1,2 Hearse et a1l noted that contracture developed when ATP levels decreased to approximately 12 ,umol/g dry weight and ATP levels further decreased to [3] [4] ,mol/g dry wt when contracture was completed. These authors suggested that contracture was associated with the development of rigor complexes that formed because of decreased levels of ATP. Other investigators suggest that reduced ATP levels may not be the only factor responsible for ischemic damage to the myocardium. [3] [4] [5] [6] [7] In studies of isolated perfused rat hearts, Neely and coworkers3,4 noted that the extent of ischemic damage did not correlate with ATP levels. Instead, recovery of function was inversely related to tissue lactate content. Perfusing hearts with lactate or depleting hearts of glycogen before ischemia resulted in increased or decreased ischemic myocardial injury, respectively. These investigators and others concluded that accumulation of by-products of anaerobic glycolytic metabolism (lactate, NADH, or H+), rather than loss of ATP, may be important in the pathogenesis of myocardial ischemic damage. [3] [4] [5] 7 Few experimental studies have evaluated the response of the hypertrophied heart to ischemia, and little is known about the role of ATP decline and lactate accumulation in ischemic hypertrophied hearts. The first descriptions of ischemic contracture or "stone heart" were noted in patients with left ventricular hypertrophy,8 suggesting that the hypertrophied myocardium may have an enhanced suscep-tibility to ischemic injury. Peyton et al9 and Attarian et al10 found that ischemic contracture occurred earlier in hypertrophied rat and dog hearts compared with normal hearts. These investigators suggested that hypertrophied hearts were more susceptible to ischemic damage because of decreased subendocardial blood flow, decreased ATP levels, and depressed mitochondrial function. Studies from our laboratory" and by Snoeckx et al'2 have shown that hypertrophied hearts from spontaneously hypertensive rats develop ischemic contracture sooner and have decreased functional recovery after ischemic contracture and reperfusion when compared with normal hearts. Thus, in both clinical and experimental studies hypertrophied hearts are more susceptible to ischemic injury.
Studies from our laboratory1314 and by others15 have noted decreased rates of 02 consumption per gram of tissue in hypertrophied rat hearts. This is consistent with other studies in which increased glycolytic enzyme levels and shifts in myosin, creatine kinase, and lactate dehydrogenase isoenzyme patterns have been reported.15-20 These isoenzyme shifts result in more anaerobic ("fetal")-type isoenzymes, with hypertrophied hearts having decreased rates of oxidative metabolism and increased anaerobic metabolism. In these studies the proportion of different isoenzymes and their messenger RNAs varies with the developmental or physiological state of the heart.16,18,2'-24 Fetal forms of the isoenzymes, including LDH-M,16,25 CK-BB,18,26 and the V3 isoform of myosin,23,24,27 are increased in hearts with chronic pressure overload-induced hypertrophy. Myosin V3 has been associated with slower contraction and more efficient use of ATP.23,28 These results suggest that the hypertrophied heart has an increased glycolytic potential.
The present study was designed to test the hypothesis that hypertrophied hearts have an increased glycolytic potential compared with nonhypertrophied hearts and that there will be an enhanced production and accumulation of glycolytic catabolites during ischemia. This increased accumulation of glycolytic by-products during ischemia may then be responsible for increased ischemic injury in hypertrophied hearts. If, on the other hand, normal and hypertrophied hearts are subjected to continuous hypoxic perfusion, glycolytic by-products will be washed out during the hypoxic insult. In this case, normal and hypertrophied hearts would have similar glycolytic by-product levels, and we would expect that the degree of hypoxic injury would be less in hypertrophied hearts because of the increased ATP production via glycolytic pathways during hypoxia. Thus, the purpose of this study was to compare the degree of ischemic and hypoxic injury in normal versus hypertrophied rat hearts to investigate the basic mechanisms responsible for irreversible myocardial ischemic injury.
Materials and Methods

Experimental Preparation
Male Sprague-Dawley rats (21 days old) were 
Experimental Protocol
The modified Langendorff isolated perfused rat heart model used in these experiments has been described. 1 
Ischemic Contracture
After the 5-minute potassium arrest, coronary flow was stopped to produce global ischemia. Left ventricular pressure was monitored throughout the ischemic interval, and the onset of ischemic contracture was recorded. After development of peak ischemic contracture, coronary flow was reinstituted with oxygenated normokalemic Krebs-Henseleit buffer, and hearts were reperfused for 30 minutes. A postischemic pressure-volume curve was generated as previously described, and the left ventricular balloon was removed. The hearts used for morphological examination were then perfusion-fixed with 15 ml of 2% phosphate buffered glutaraldehyde at 100 mm Hg pressure. Another group of hearts were made ischemic until contracture, were reperfused for 30 minutes with oxygenated buffer, and after the left ventricular balloon was removed, were perfused with Monastral blue dye (Sigma Chemical Co., St. Louis) to delineate the area of no-reflow. A constantpressure (100 mm Hg) system was used to infuse the Monastral dye into the aortic cannula to assure reproducible controlled injections. The hearts were then immersion-fixed in 10% buffered formalin and cut into six equal transverse slices. These slices were photographed and weighed. Monastral dye delineated the areas of flow within the myocardium. Photographs of all heart slices were traced around perfused and nonreperfused areas with a sonic digitizing system interfaced to a computer; by using the weight of each tissue slice, the percent of nonreperfused myocardium was quantitated.
To characterize the degree of ischemic injury, the preischemic and postischemic left ventricular pressure volume curves were compared. At each balloon volume increment, the end-diastolic and developed left ventricular pressures were recorded. To determine the percent recovery of left ventricular function, the postischemic left ventricular developed pressure of each heart at the 20-,ll balloon volume increment was divided by the preischemic left ventricular pressure at the same balloon volume. Another method used to characterize postischemic myocardial injury was to compare the end-diastolic pressure at each balloon volume increment before and after ischemia. To do this, the postischemic end-diastolic pressure was subtracted from the preischemic end-diastolic pressure at each balloon volume. This difference in preischemic and postischemic end-diastolic pressures was then plotted versus balloon volume, and the slope of this line was determined by linear regression analysis. The steepness of this slope is an indicator of myocardial stiffness and thus can be equated to the degree of myocardial injury.29 This myocardial stiffness constant was used to compare the degree of myocardial injury in BAND and SHAM hearts.
Hypoxic Perfusion
After 5 minutes of potassium arrest, the coronary perfusate was switched to Krebs-Henseleit buffer gassed with 95% N2 and 5% CO2 in which glucose had been replaced by an equimolar amount of mannitol. During the 15-minute hypoxic perfusion, total coronary effluent was collected, and samples were analyzed at 1-minute intervals for the first 5 minutes and again at 10 and 15 minutes. After 15 minutes of hypoxia, hearts were reoxygenated with oxygenated normokalemic buffer, and coronary effluent samples were again collected at 1-minute intervals for the first 5 minutes and again at 10, 15, and 20 minutes of reoxygenation. A posthypoxic pressure-volume curve was generated to compare with the prehypoxic curve, and the percent recovery of left ventricular pressure as well as the myocardial stiffness constant were determined as described above for the ischemic perfusion protocol. The left ventricular balloon was removed, and hearts were perfusion fixed with 15 ml of 2% phosphate buffered glutaraldehyde at 100 mm Hg pressure. High-Pressure Liquid Chromatography and
Biochemical Determinations
Additional BAND and SHAM hearts were isolated and either quickly frozen with liquid nitrogencooled Wollenberger clamps after 15 minutes of control perfusion or subjected to ischemic or hypoxic perfusion protocols as described above and freezeclamped at specific time points. Sections of left ventricular tissue from these frozen hearts were used for high-pressure liquid chromatography (HPLC), lactate, glycogen, and water content determinations. For HPLC and lactate measurements, tissues were weighed, pulverized under liquid nitrogen in a mortar and pestle, and mixed with ice-cold 6% perchloric acid; after extraction, samples were neutralized with 5 M potassium carbonate to a pH of 7.4±0.3 and centrifuged at 40 C.3 These tissue extracts were used for HPLC analysis (described below) and for lactate determination with standard enzymatic spectrophotometric techniques (Sigma). Myocardial glycogen was determined by treatment of tissues with 30% KOH, followed by acid hydrolysis of the glycogen, and glucose was measured spectrophotometrically. 30 Tissue glycogen levels are expressed as glucose equivalents per gram of dry heart weight. Lactate and lactate dehydrogenase (LDH) levels were determined in coronary effluent samples by standard enzymatic spectrophotometric techniques (Sigma). The Tables 2 and 3 , Control).
The energetic status of the hearts was determined by HPLC analysis of ATP and phosphocreatine (PCr). These levels were determined by a reverse-phase ion-paired HPLC system (Waters Corp., Milford, Mass.). Tetrabutylammonium hydroxide (TBAH) was used as the ion-pair agent.31 The two-solvent mobile phase consisted of solution A (100 mM KH2P04, 2.5 mM TBAH, pH 4.4) and solution B (100 mM KH2PO4, 15 mM TBAH, 30% methanol, pH 5.9). A gradient control with an initial flow ratio of 1:0 (A: B) ran for 3 minutes followed by a 12-minute ramp to a flow ratio of 1:9. This ratio was maintained for 1.4 minutes followed by a 2.5-minute ramp back down to a ratio of 1:0, then a 15.1-minute reequilibration. The samples were stored in a refrigerated (10 C) autosampler until they were analyzed. The column was maintained at 30°C. The system was calibrated with known amounts of pure standards at the beginning of each run, and standards were interspersed throughout the unknown samples in each run.
Morphological Evaluation
Ten transmural tissue samples from the left and right ventricles of each perfusion-fixed heart were embedded in Spurr epoxy resin. Serial 1-gm sections from each block were affixed to glass slides and stained with toluidine blue for light microscopic examination. From these sections, representative areas from the endomyocardium, midwall, and epimyocardium were identified. The tissue blocks were trimmed, and ultrathin sections were cut for examination by transmission electron microscopy.
Data Analysis
All data are expressed as mean±SEM, except where otherwise noted. Statistical evaluation between groups was done by Student's t test.
Results
The model of pressure-overload cardiac hypertrophy that was used in these experiments involves placing a mildly occlusive band on the ascending aorta of 23-day-old rats. As the rat grows from 50 g at 23 days of age to approximately 350 g at 8 weeks postbanding, the aortic coarctation becomes relatively more constricting. Aortic banding produced significant cardiac hypertrophy in BAND compared with SHAM at 8 weeks postbanding (Table 1, Figure  1 ). There was a modest reduction in body weight gain in BAND; however, absolute heart weights were increased by 87%. This model of cardiac hypertrophy produced significant increases in the weights of the left ventricle plus septum, the right ventricle, and the atria. Early signs of congestive heart failure developed in some rats by 8 weeks, with pleural fluid accumulation, mild evidence of pulmonary congestion and edema, and hepatic congestion.
Basal coronary flow rates in these isolated perfused hearts, expressed as milliliters per minute per gram wet heart weight, were lower in BAND (9.7+0.52) compared with SHAM (14.2+0.75, p<0.01). MVo2 was measured while the isolated buffer-perfused hearts were paced at 300 beats/min and the intraventricular balloon was inflated such that the heart was producing 60 mm Hg developed left ventricular pressure. The MVo2 of beating hearts Because each heart was reperfused at peak contracture, the mean total ischemic time was similar in BAND and SHAM. The developed left ventricular pressure and the heart rate were variable during the initial reperfusion period (Figure 2 19-34 mm Hg at a pH range of 7.34-7.45. After the 5-minute potassium arrest, the isolated hearts were perfused with hypoxic buffer at 100 mm Hg. The potassium-arrested hearts began beating immediately after perfusion with hypoxic buffer (electrical pacer was off), but the left ventricular developed pressure quickly fell (Figure 3) . By 3-4 minutes the hearts stopped beating, and the left ventricular end-diastolic pressure began to rise. This hypoxic contracture curve was steeper than the ischemic contracture curve, and contracture was complete in both BAND and SHAM within 2 minutes. During hypoxic perfusion, coronary flow increased slightly in both BAND and SHAM, but this change was not statistically significant. After 15 minutes of hypoxia, hearts were reoxygenated with oxygenated buffer containing glucose. End-diastolic pressure decreased significantly after reoxygenation and continued to decrease during the reoxygenation period, but did not reach prehypoxic levels. Left ventricular developed pressure increased throughout the reoxygenation period. The hearts, areas of no-reflow were not seen; thus, collection of coronary effluent gives an accurate assessment of interstitial metabolite and enzyme levels. Lactate release into the coronary effluent increased sharply in both groups during hypoxia, peaked after 2-3 minutes in SHAM, but continued to increase in BAND ( Figure 4 ). Total lactate release during the entire 15-minute hypoxic period was significantly higher in BAND compared with SHAM. Lactate levels in the coronary effluent were insignificant during reoxygenation. LDH release during hypoxia was no different from control values ( Figure 5 ). However, immediately after reoxygenation, LDH levels increased significantly in both groups. The amount and duration of LDH release was less in BAND than in SHAM, indicating less myocyte injury in BAND. The myocardial ATP, PCr, and glycogen contents in hypoxic perfused hearts are shown in Table 3 . After 8 minutes of hypoxic reperfusion, PCr levels were significantly decreased compared with prehypoxic control values in both groups. ATP levels were also markedly decreased compared with control, but ATP was higher in BAND compared with SHAM * hearts. Glycogen levels tended to be lower in BAND than SHAM, but this difference was not statistically significant. At the end of hypoxic perfusion, all values were markedly reduced compared with controls, but there were no differences between BAND and SHAM. After 20 minutes of reoxygenation, the PCr levels were improved but were lower in BAND than SHAM. There was only modest recovery of ATP and glycogen in both groups.
Morphology of Ischemic and Hypoxic Injury
Nonischemic and nonhypoxic hearts from BAND and SHAM rats were examined by light and electron microscopy. There was a mild increase in fibrous connective tissue in BAND, predominantly in the subendocardial region. There was no evidence of ongoing inflammation or necrosis in any heart from either group. The morphological changes of ischemic contracture and reperfusion in the BAND and SHAM hearts from this study are similar to the changes described in our previous studies with hearts from normal and spontaneously hypertensive rats." During ischemic contracture there were significant morphological changes consistent with ischemic injury, but no changes that would definitively demonstrate lethal myocyte injury, that is, sarcolemmal disruption or contraction band necrosis. After ischemic contracture and reperfusion there was a distinct zone of contraction band change at the flow/noreflow border ( Figure 6 ). The morphological changes in BAND and SHAM hearts were identical, except that the area of no-reflow was greater in BAND. The myocardial injury in hearts from both hypoxic groups was less severe than the changes seen after ischemic injury, and no differences were noted between BAND and SHAM. There were no grossly visible areas of no-reflow in hearts perfused with Monastral dye after hypoxia and reoxygenation. The time course of morphological changes was consistent with the time course of LDH release in that only minimal LDH was present in the coronary effluent during hypoxia, but with reoxygenation there was a substantial release of LDH. There were multifocal areas of contraction band change throughout the myocardium (Figure 7 ). These lesions occurred throughout all regions of the myocardium, with no apparent predilection for endomyocardium, midwall, or epimyocardium. Ultrastructural changes in myocytes from both The results of this study demonstrate that hypertrophied BAND hearts are more susceptible to ischemic injury than are normal SHAM hearts. However, if hearts are subjected to continuous hypoxic perfusion, hypertrophied hearts are less sensitive to hypoxic myocardial damage than normal hearts. Taken together, these data suggest that in this model of pressure-overload hypertrophy, the increased rate of glycolytic metabolism results in a more rapid accumulation of glycolytic by-products during ischemia, which contribute to the increased susceptibility of hypertrophied hearts to ischemic injury.
The increased susceptibility of hypertrophied hearts to ischemic injury has been known for many years, but the pathogenetic mechanisms are not well understood.8-12,32-34 Neely and colleagues3,4 have shown that by-products of glycolytic metabolism, especially lactate, NADH, and H, may play an important role in the pathogenesis of ischemic myocardial injury. In their studies of isolated working rat hearts, the extent of myocardial injury was greater in hearts that were perfused with lactate before ischemia. Conversely, if hearts were depleted of glycogen, thereby decreasing the amount of lactate produced during ischemia, the degree of ischemic myocardial injury was markedly decreased. Changes in myocardial ATP levels during these studies did not correlate with the degree of myocardial injury. Thus, these studies show that lactate levels and not ATP may be important in ischemic myocardial injury.
In the present study with BAND hearts, hypertrophied hearts were more susceptible to ischemic injury than were normal hearts. The hypertrophied hearts in this study also had higher lactate levels during ischemia than did controls, although lactate levels at peak contracture were not different. This suggests that hypertrophied hearts have an increased glycolytic potential, which resulted in an increased accumulation of glycolytic by-products during ischemia. PCr and ATP levels were lower in hypertrophied hearts before ischemia, but after 5 minutes of potassium arrest these differences were partially mollified. During the ischemic insult, there were no differences in PCr or ATP levels between hypertrophied and normal hearts, despite the significant differences in lactate levels and functional recovery. With hypoxic perfusion, lactate production was again increased in hypertrophied hearts; however, the continuous perfusion washed the lactate out of the tissue. During the hypoxic period there were no significant differ-ences in PCr or ATP in the hypertrophied and normal hearts. After posthypoxic reoxygenation, the hypertrophied hearts had less myocardial injury as evidenced by lower LDH release and better functional recovery than controls. ATP levels were similar in both groups after 20 minutes of reoxygenation; however, PCr was decreased in the hypertrophied hearts. These findings suggest that the increased glycolytic potential of hypertrophied hearts has a protective effect during hypoxia, when glycolytic byproducts are not allowed to accumulate in the myocardial tissue.
Previous studies have shown that hypertrophied hearts have increased glycolytic enzyme levels and shifts in myosin, creatine kinase, and LDH isoenzyme patterns.15-20 These isoenzyme shifts result in more anaerobic (fetal)-type isoenzymes, with hypertrophied hearts having decreased rates of oxidative metabolism and increased anaerobic metabolism. This is consistent with our previous studies, which noted decreased rates of 02 consumption per gram of tissue in hypertrophied rat hearts, again suggesting decreased dependence on aerobic metabolism.13 '14,27 The hypertrophied hearts used in the present studies also had decreased rates of 02 consumption per gram of tissue, both while beating and during potassium arrest. Additionally, lactate accumulation during ischemia was increased, providing further support for an increased glycolytic potential in hypertrophied hearts.
In contrast to the findings in this study, Cunningham et a135 recently reported decreased lactate release from hypertrophied hearts of deoxycorticosterone-salt hypertensive rats during hypoxic perfusion. These investigators used a different model of cardiac hypertrophy than the model used for this study, and in contrast to our study, they included glucose and lactate in the perfusate during the 15-minute hypoxic perfusion. These differences in the experimental protocol may account for the differences seen in their study compared with the present study.
Many studies of hearts from neonates have also demonstrated an enhanced glycolytic potential. [36] [37] [38] [39] [40] In studies of neonatal hearts subjected to continuous hypoxic perfusion, tissue ATP levels did not fall as fast or as far as in adult hearts, and functional recovery was greater in the neonatal hearts,37 suggesting a protective effect of increased glycolysis. In ischemic injury studies with rat, rabbit, dog, and pig hearts, there was a decreased time to develop ischemic contracture, an increased lactate accumulation during ischemia, and decreased postischemic functional recovery in neonatal hearts compared with adult hearts.38-40 Thus, glycolytic by-product accumulation during ischemia appears to have an important detrimental effect on the ischemic neonatal myocardium. However, other studies have shown that neonatal hearts are in fact less sensitive to ischemic injury than adult hearts. 41, 42 Thus, controversy does exist in this area, and further work needs to be done to resolve these issues.
The studies described in this report, with the isolated buffer-perfusate rat heart, do not attempt to recapitulate regional ischemia during myocardial infarction or intraoperative cardioplegic arrest in humans. Instead, this model system allows us to manipulate the experimental conditions and, with proper experimental design, answer specific questions about the basic mechanisms of ischemic myocardial injury. The results of this study suggest that in the hypertrophied heart, compensatory changes resulting in an increased rate of glycolytic metabolism may ultimately make the heart more susceptible to ischemic injury. Specifically, the increased glycolytic potential in hypertrophied hearts leads to increased accumulation of glycolytic by-products during ischemia and results in increased ischemic myocardial damage. Conversely, when glycolytic by-products are removed, as in hypoxic perfusion and perhaps in ischemic conditions with collateral flow, the increased rate of glycolytic metabolism of the hypertrophied heart provides some protection against injury. The exact mechanisms involved in this process and the role of other factors involved in the development of irreversible ischemic injury remain to be elucidated.
